News
DelveInsight's Claudin 18.2 Directed Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report ...
The Swiss company, which markets Elevidys abroad, said it believes the benefit-risk balance to treatment remains positive in ...
14h
Zacks Investment Research on MSNUnited Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?United Therapeutics (UTHR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports ...
USA News Group News Commentary – Cancer diagnoses are climbing fastest among younger women, sparking alarm that looming cuts ...
Roche Holding AG said on Tuesday it has paused shipments of muscular disorder gene therapy Elevidys in some countries outside ...
Logo Chill Factor Cooling & Heating offers 10% off HVAC services for military and first responders in Norco, CA. Trusted lo ...
Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement ...
The abstracts accepted for mini oral presentations include updated efficacy and safety data from the Phase 2b REZILIENT1 ...
Aquestive Therapeutics, Inc. (NASDAQ: AQST) ('Aquestive” or the 'Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...
United Therapeutics Corporation (UTHR) Completes Phase 3 Enrollment for Promising PAH Drug Ralinepag
United Therapeutics Corporation (NASDAQ:UTHR) is among the most undervalued stocks to invest in. It is a biotechnology ...
The price of every home shirt released so far in the Championship for 2025/26 as Sheffield Wednesday test their supporters ...
Against that backdrop, United Therapeutics is facing specific questions about near-term sales performance, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results